THE BASIC PRINCIPLES OF PHARMACEUTICAL EXCIPIENTS

In the same 12 months the ITC also described on their efforts in the direction of the flow syntheses of two guide compounds claimed previously by AstraZeneca. The initial 1 details the move synthesis of a strong 5HT1B antagonist (28) which was assembled through a 5 step continual synthesis which include a SNAr reaction, heterogeneous hydrogenation,